Peyona 20 mg (Caffeine Citrate SOLUTION) 20 MG

Peyona 20 mg is a caffeine citrate solution used for intravenous administration. It is commonly used to stimulate breathing in premature infants. This medication is manufactured by Chiesi Farmaceutici S.p.A. in Italy.

Strength

20 MG

Manufacturer / TM Owner

CHIESI FARMACEUTICI S.P.A.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Peyona 20 mg is primarily used to stimulate respiratory drive in premature infants who experience breathing difficulties. Caffeine citrate, the active ingredient, helps to reduce the frequency of apnea and improve breathing patterns. This medication is often administered in neonatal intensive care units to support respiratory function in newborns.

Side Effects

Common effects of Peyona 20 mg may include increased alertness and improved breathing in premature infants. The medication works by stimulating the respiratory center in the brain, which can help regulate breathing. Some infants may experience temporary side effects, but these are generally mild and manageable.

Precautions & Warnings

Peyona 20 mg should be administered under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration guidelines to ensure safety. Patients with certain medical conditions or allergies should inform their healthcare provider before using this medication.

Avoid Interactions

Peyona 20 mg may interact with other medications, including those that affect the central nervous system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with caffeine citrate, so it is advisable to consult with a healthcare professional.

Frequently Asked Questions

Peyona 20 mg is used to stimulate breathing in premature infants who experience respiratory difficulties.

Peyona 20 mg is administered intravenously, typically in a hospital or clinical setting under the supervision of a healthcare professional.

Common effects include increased alertness and improved breathing in premature infants.

Yes, it should be administered under medical supervision, and patients with certain conditions or allergies should inform their healthcare provider.

Yes, it may interact with other medications, especially those affecting the central nervous system. Always consult a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.